# Avelos Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/avelos-therapeutics

- Industry: Biotechnology
- Headquarters: Seoul, South Korea
- Website: www.avelostx.com/en
- Total disclosed funding: $20M
- Latest round: Series B (Apr 30, 2024)
- Investors on record: 13

## About

Founded in 2021, and based in Seoul, South Korea, Avelos Therapeutics Inc. operates as a research company that develops various technologies. In July 2022, Avelos Therapeutics Inc. raised KRW 10 billion in a series A with funding from UTC Investment, Time Folio Asset Management, SV Investment, and many more. As of 2022, the company is led by its CEO, Young-Whan Park.

The company offers various targeted oncology medicine applications that include cell cycle regulation, undruggable cancer targets, and DNA damage for synthetic lethality.

The company plans to use the July 2022 funding for research and development and to build four projects centered on the synthetic lethal field. In addition, two projects aim to advance to the clinical stage by 2025.

## Funding rounds

- Series B, Apr 30, 2024, $12M — Shinhan Capital, SV Investment, Mirae Asset Venture Investment, QUAD Investment Management, Heungkuk Securities, Timefolio Capital, LSK Investment, Stassets Investment, Medytox Venture Investment
- Series A, Jul 18, 2022, $7.6M — Mirae Asset Capital, SV Investment, UTC Investment, Mirae Asset Venture Investment, Time Folio Asset Management, QUAD Ventures

## Investors

- Mirae Asset Capital (https://capitalatlas.ai/funds/mirae-asset-capital) — Series A
- SV Investment (https://capitalatlas.ai/funds/sv-investment) — Series A, Series B
- UTC Investment (https://capitalatlas.ai/funds/utc-investment) — Series A
- Mirae Asset Venture Investment (https://capitalatlas.ai/funds/mirae-asset-venture-investment) — Series A, Series B
- Time Folio Asset Management — Series A
- QUAD Ventures (https://capitalatlas.ai/funds/quad-ventures) — Series A
- Shinhan Capital (https://capitalatlas.ai/funds/shinhan-capital) — Series B
- QUAD Investment Management (https://capitalatlas.ai/funds/quad-investment-management) — Series B
- Heungkuk Securities — Series B
- Timefolio Capital — Series B
- LSK Investment (https://capitalatlas.ai/funds/lsk-investment) — Series B
- Stassets Investment (https://capitalatlas.ai/funds/stassets-investment) — Series B
- Medytox Venture Investment (https://capitalatlas.ai/funds/medytox-venture-investment) — Series B